| Particulars |
| Company Name
| Remus Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (र)Cr. |
11.78 |
B.V.Rs |
276.40 |
| Sales (र)Cr. |
93.99 |
NP Rs Cr. |
24.71 |
| NP Var% |
25.00 |
Div% |
5.00 |
| CPS (र) |
23.30 |
EPS Rs |
21.00 |
| Traded Value (र)Lakhs |
0.00 |
52 Week High |
988.00 |
| 52 Week Low |
580.00 |
Price BSE |
0.00 |
| Price NSE |
893.00 |
Market Capital(Rs Cr.) |
1,052.37 |
| P/C Ratio |
38.30 |
P/E Ratio |
42.60 |
| Price Vs.BV |
3.23 |
|
| Latest Quarter |
| Year End |
0 |
Sales Rs Cr. |
0.00 |
| NP (र)Cr. |
0.00 |
NP Var % |
0.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
0.00 |
| OPM |
0.00 |
NP |
0.00 |
| NP Var% |
25.11 |
EPS |
20.97 |
| PE |
42.59 |
|
|